Market Cap (In CHF)
1.67 Billion
Revenue (In CHF)
320.02 Million
Net Income (In CHF)
26.31 Million
Avg. Volume
9717.00
- Currency
- CHF
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 69.4-86.6
- PE
- -
- EPS
- -
- Beta Value
- 0.955
- ISIN
- CH0013396012
- CUSIP
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Thomas Huber
- Employee Count
- -
- Website
- https://skan.com/de/home/
- Ipo Date
- 2021-12-28
- Details
- SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
More Stocks
-
002045
-
0A1O
-
GPPL
-
INTEU
-
GIGANTEGrupo Gigante, S. A. B. de C. V.
GIGANTE
-
OHCS
-
PXPHFPexip Holding ASA
PXPHF
-
LANDLandis+Gyr Group AG
LAND